Skip to main content

Table 1 Patient characteristics

From: Customized chemotherapy based on epidermal growth factor receptormutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial

  All Gefitinib VNR or GEM P
Age (years)     
Median (range) 80 (71–89) 81 (71–85) 79 (72–89) 0.11
Male:Female 20:34 5:17 15:17 0.09
ECOG PS     
0:1 12:42 8:14 4:28 0.05
Histology     
Adeno 37 21 16 < 0.001
Squamous 8 1 7  
Other 9 0 9  
Smoking history     
Never 29 16 13 0.03
Former / current 25 6 19  
Mutation type     
Exon 19 del 6 6
Exon 21 L858R 14 14  
Ex19del + L858R 2 2  
Clinical stage     
IIIB 20 9 11 0.78
IV 34 13 21  
  1. ECOG PS: Eastern Cooperative Oncology Group Performance Status; GEM: gemcitabine; VNR: vinorelbine.